FDA NDC Directory · JSON-LD · Markdown

VENLAFAXINE HYDROCHLORIDE

NDC 62332-792 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA217767
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsVENLAFAXINE HYDROCHLORIDE (37.5 mg/1)
Marketing started20240610
Package count5

External sources

Source: openFDA. Public-domain (CC0).